Akoya Biosciences, Inc. (AKYA) revealed Loss for fourth quarter that decreased from the same period last year but missed the Street estimates.
The company's bottom line came in at -$8.20 million, or -$0.17 per share. This compares with -$10.80 million, or -$0.22 per share, last year.
Analysts on average had expected the company to earn -$0.16 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period fell 19.4% to $21.34 million from $26.49 million last year.
Akoya Biosciences, Inc. earnings at a glance (GAAP) :
-Earnings: -$8.20 Mln. vs. -$10.80 Mln. last year.-EPS: -$0.17 vs. -$0.22 last year.-Revenue: $21.34 Mln vs. $26.49 Mln last year.
For comments and feedback contact: editorial@rttnews.com
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.